The comparison of predictive factors regarding prognoses and invasion of thymic neuroendocrine tumors preoperatively and postoperatively

被引:10
作者
Bian, Dongliang [1 ]
Qi, Mengfan [1 ]
Hu, Junjie [1 ]
Ning, Ye [1 ]
Zhou, Feng [1 ]
Fei, Ke [1 ]
Zhang, Peng [1 ]
机构
[1] Tongji Univ, Affiliated Shanghai Pulm Hosp, Dept Thorac Surg, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
关键词
Chemotherapy; radiotherapy; surgery; neuroendocrine tumors (NETs); prognoses; PERIOPERATIVE CHEMOTHERAPY; ADVANCED THYMOMA; CANCER; SURVIVAL; CARCINOMA; SURGERY; TRIAL; POPULATION; ESOPHAGEAL; OUTCOMES;
D O I
10.21037/jtd.2018.02.82
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Thymic neuroendocrine tumors (TNT), in the anterior mediastinum, are extremely rare diseases which have significantly poor prognoses. Studies have rarely provided conclusive evidence of the prognostic factors of TNT. Standard therapies have been controversial. Methods: TNT patients (n=173) were enrolled from Surveillance, Epidemiology and End Results database (SEER). Univariate and multivariate analyses were utilized to evaluate predictive factors of prognoses. Logistic regression analysis was used to assess the plausible correlation between histological grade, and cancer invasion. Stratification analysis was used to evaluate the effectiveness of adjuvant therapies. Results: According to our analysis, local Masaoka stage, surgery, radiotherapy, and non-chemotherapy predicted better overall survival (OS) (P<0.05, for all) in 173 TNT patients. We found that the higher the histological grade of the tumor, the greater the rate of metastasis (P<0.05). The focus was on 125 surgically treated patients, who were females with poor prognostic factors of OS, upgraded histological grade, and advanced Masaoka stage (P<0.01, for all). The effectiveness of radiotherapy treatments had discrepancies at different clinical stages. In the local stage, radiotherapy caused significantly worse OS (P=0.011), while in the advanced stage, patients demonstrated significantly better OS with this treatment (P=0.028). Chemotherapy caused worse OS, primarily, in females (P=0.028). Conclusions: Surgery, Masaoka stage, and adjuvant treatments were prognostic factors. With surgically treated TNT, gender, histological grade, and Masaoka stage predicted significantly worse OS. Chemotherapy decreased female patients' OS. Radiotherapy significantly promoted advanced and local advanced patients' OS; however, it decreased local stage patients' OS. Predicted TNT invasiveness significantly correlated with histological grade.
引用
收藏
页码:1657 / 1669
页数:13
相关论文
共 31 条
[21]   State of the art: diagnostic tools and innovative therapies for treatment of advanced thymoma and thymic carcinoma [J].
Ried, Michael ;
Marx, Alexander ;
Gotz, Andrea ;
Hamer, Okka ;
Schalke, Berthold ;
Hofmann, Hans-Stefan .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (06) :1545-1552
[22]   Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine [J].
Sakuramoto, Shinichi ;
Sasako, Mitsuru ;
Yamaguchi, Toshiharu ;
Kinoshita, Taira ;
Fujii, Masashi ;
Nashimoto, Atsushi ;
Furukawa, Hiroshi ;
Nakajima, Toshifusa ;
Ohashi, Yasuo ;
Imamura, Hiroshi ;
Higashino, Masayuki ;
Yamamura, Yoshitaka ;
Kurita, Akira ;
Arai, Kuniyoshi .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) :1810-1820
[23]   Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience [J].
Savic, Milan ;
Kontic, Milica ;
Ercegovac, Maja ;
Stojsic, Jelena ;
Bascarevic, Slavisa ;
Moskovljevic, Dejan ;
Kostic, Marko ;
Vesovic, Radomir ;
Popevic, Spasoje ;
Laban, Marija ;
Markovic, Jelena ;
Jovanovic, Dragana .
THORACIC CANCER, 2017, 8 (05) :393-401
[24]   Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954 [J].
Schuhmacher, Christoph ;
Gretschel, Stephan ;
Lordick, Florian ;
Reichardt, Peter ;
Hohenberger, Werner ;
Eisenberger, Claus F. ;
Haag, Cornelie ;
Mauer, Murielle E. ;
Hasan, Baktiar ;
Welch, John ;
Ott, Katja ;
Hoelscher, Arnulf ;
Schneider, Paul M. ;
Bechstein, Wolf ;
Wilke, Hans ;
Lutz, Manfred P. ;
Nordlinger, Bernard ;
Van Cutsem, Eric ;
Siewert, Joerg R. ;
Schlag, Peter M. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) :5210-5218
[25]   Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas:: A retrospective analysis [J].
Ströbel, P ;
Bauer, A ;
Puppe, B ;
Kraushaar, T ;
Krein, A ;
Toyka, K ;
Gold, R ;
Semik, M ;
Kiefer, R ;
Nix, W ;
Schalke, B ;
Müller-Hermelink, HK ;
Marx, A .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1501-1509
[26]   Neuroendocrine Tumors of the Thymus: Analysis of Factors Affecting Survival in 254 Patients [J].
Sullivan, Jennifer L. ;
Weksler, Benny .
ANNALS OF THORACIC SURGERY, 2017, 103 (03) :935-939
[27]  
Travis WD, 2004, PATHOLOGY GENETICS T, P145
[28]   Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer [J].
van Hagen, P. ;
Hulshof, M. C. C. M. ;
van Lanschot, J. J. B. ;
Steyerberg, E. W. ;
Henegouwen, M. I. van Berge ;
Wijnhoven, B. P. L. ;
Richel, D. J. ;
Nieuwenhuijzen, G. A. P. ;
Hospers, G. A. P. ;
Bonenkamp, J. J. ;
Cuesta, M. A. ;
Blaisse, R. J. B. ;
Busch, O. R. C. ;
ten Kate, F. J. W. ;
Creemers, G. -J. ;
Punt, C. J. A. ;
Plukker, J. T. M. ;
Verheul, H. M. W. ;
Bilgen, E. J. Spillenaar ;
van Dekken, H. ;
van der Sangen, M. J. C. ;
Rozema, T. ;
Biermann, K. ;
Beukema, J. C. ;
Piet, A. H. M. ;
van Rij, C. M. ;
Reinders, J. G. ;
Tilanus, H. W. ;
van der Gaast, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (22) :2074-2084
[29]   One hundred years after "Carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States [J].
Yao, James C. ;
Hassan, Manal ;
Phan, Alexandria ;
Dagohoy, Cecile ;
Leary, Colleen ;
Mares, Jeannette E. ;
Abdalla, Eddie K. ;
Fleming, Jason B. ;
Vauthey, Jean-Nicolas ;
Rashid, Asif ;
Evans, Douglas B. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (18) :3063-3072
[30]   Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial [J].
Ychou, Marc ;
Boige, Valerie ;
Pignon, Jean-Pierre ;
Conroy, Thierry ;
Bouche, Olivier ;
Lebreton, Gilles ;
Ducourtieux, Muriel ;
Bedenne, Laurent ;
Fabre, Jean-Michel ;
Saint-Aubert, Bernard ;
Geneve, Jean ;
Lasser, Philippe ;
Rougier, Philippe .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) :1715-1721